Anat Shievan

Title: Anat Shievan: Innovator in Membrane-Binding Compounds

Introduction

Anat Shievan is a notable inventor based in Herzliya, Israel. He has made significant contributions to the field of biotechnology, particularly in the development of compounds that interact with cellular membranes. His innovative work has led to the creation of a unique class of compounds that have potential applications in various medical fields.

Latest Patents

Anat Shievan holds one patent titled "Perturbed Membrane-Binding Compounds." This invention provides uses for compounds that selectively bind to cells undergoing perturbations and alterations in their normal membrane organization. These compounds, known as perturbed-membrane-binding compounds (PMBC), exhibit a lesser degree of binding to cells with normal membrane organization. The PMBC group includes both new and known compounds, showcasing the versatility and potential impact of his research.

Career Highlights

Anat Shievan is associated with Nst Neurosurvival Technologies Ltd, where he continues to advance his research and development efforts. His work focuses on understanding cellular interactions and the implications of membrane organization in health and disease.

Collaborations

Anat collaborates with talented individuals in his field, including Ilan Ziv and Sharon Ebner. These partnerships enhance the innovative potential of his projects and contribute to the advancement of their shared goals.

Conclusion

Anat Shievan's contributions to the field of membrane-binding compounds highlight his role as an influential inventor. His work not only advances scientific understanding but also opens new avenues for medical applications.